Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06275737 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric

Study acronym: POP-UP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from GERCOR - Multidisciplinary Oncology Cooperative Group

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 6 more changesShow less
    • Enrollment reopened
    • Enrollment increased: 9 → 72 participants
    • Study sites: 10 to 11
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints revised (29)
    • Study description expanded, about 3 words
  2. Primary endpoint revisedv4 Show 7 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 72 to confirmed 9
    • Study sites: 4 to 10
    • Secondary endpoints: 16 to 29
    • Study description shortened, about 25 words
    • Eligibility criteria shortened, about 1 word
    • Study title expanded, about 5 words
  3. Primary completion date: Mar 2027 to Dec 2027
    • Study completion date: Mar 2027 to Jun 2028
    • Start date changed from estimate of Aug 2024 to Jun 24, 2024
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 2024 to Aug 2024
    • Study sites: 0 to 4
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, multicenter, two-cohort, open-label, single-arm feasibility study of a trimodal (nutritional, psychological, and personalized Adapted Physical Activity (APA)-individualized interventions) 8-week prehabilitation program in patients with localized pancreatic ductal adenocarcinoma (PDAC) or oesogastric cancer (OGC) receiving peri-operative triple chemotherapy and undergoing surgery.
Trial Details
NCT Number NCT06275737
Lead Sponsor GERCOR - Multidisciplinary Oncology Cooperative Group
Conditions
(from sponsor)		 Pancreatic Ductal Adenocarcinoma, Esophageal Cancer
Related terms Esophageal Neoplasms
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov